mRNA |
ML311 |
CTRPv2 |
pan-cancer |
AAC |
0.027 |
0.4 |
mRNA |
BIBW2992 |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.4 |
mRNA |
SR1001 |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.4 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.4 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.4 |
mRNA |
AZD-2281 |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |
mRNA |
pac-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |
mRNA |
LRRK2-IN-1 |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.4 |
mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
0.027 |
0.4 |
mRNA |
Bosutinib |
FIMM |
pan-cancer |
AAC |
-0.3 |
0.4 |